Along with its needed effects, a medicine may cause some unwanted effects
A
Selegiline is used to help control the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance)
Common Brand (S): Eldepryl
Memory and learning deficits are induced by: 1) lesioning cholinergic structures such as the nuclei basales of Meynert, 2) pharmacologically intervening with
Alzheimer's disease results in a loss of memory, cognition and judgment
Overdose
Selegiline is a prescription medication that helps reduce symptoms of early-stage Parkinson’s disease and is also effective against depression
Metrics
While the participants we studied have memory deficits, their memory difficulties do not explain our language findings, as
Poor spatial navigation could be a sign of Alzheimer’s disease more than 20 years before memory loss starts, according to a new study
This document does not contain all possible interactions from the use of this medication
Orally disintegrating tablet: Rapid; greater bioavailability than capsule/tablet
This medication is usually used at a later stage of Parkinson's disease and in combination with Sinemet®
Food and Drug Administration (FDA) for the treatment of Parkinson disease
Here, we evaluated the effects of selegiline only or its combined use with donepezil, a
Selegiline skin patch should not be used in children younger than 12 years of age
Two major recognitions were
The mechanisms accounting for selegiline’s beneficial adjunctive action in the treatment of Parkinson’s disease are not fully understood
Children—Use and dose must be determined by your doctor
View Selegiline’s uses, side-effects, drug interactions, expert advice and user FAQs only on 1mg
31m+ Orders Delivered
The following side effects of oral selegiline capsules are considered mild and typically improve with time : Loss of balance or lightheadedness; Fainting;
Selegiline, N -methyl- N - (2-propinyl)-2-methyl-1-phenylethylamine (10
resulted in loss of clinical effect, suggesting no contribution of amphetamines to the clinical benefit in Parkinson’s disease Finali G, Piccirilli M, Oliani C, Piccinin GL
In lower doses it inhibits MAO-B, and it can also inhibit MAO-A in higher doses
Its typical clinical manifestation includes bradykinesia, rigidity, rest tremor and disturbances in balance (Obeso et al
It is in a class of medications known as selective inhibitors of monoamine oxidase type B
contraindicated w/in 14 days of selegiline or atomoxetine use: combo may incr
Selegiline Interactions